{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:31:25Z","timestamp":1788449485631,"version":"build-2803163510"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cancer Center Support","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Advances in care have led to improvements in survival for adolescents and young adults (AYAs) diagnosed with cancer; however, the risk of early death remains high for certain cancers, particularly acute leukemias. Risk factors for early death in AYAs diagnosed with acute leukemia have not been well studied.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The Surveillance, Epidemiology, and End Results registry was used to assess risk of early death (within 2 months of diagnosis) in AYAs diagnosed with acute leukemia (n\u2009=\u200916\u2009153). Early death proportion, by year, for AYAs diagnosed between 2006 and 2020 was described. Associations between incidence of early death and age at diagnosis, sex, race and ethnicity, socioeconomic status, rurality, acute leukemia type, and year of diagnosis were evaluated with logistic regression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, 6.0% of AYAs experienced early death and there was a significant annual decrease in the odds of early death (odds ratio [OR] = 0.96, 95% confidence interval [CI] = 0.95 to 0.98, P\u2009&amp;lt;\u2009.0001) across the study period. Over the entire study period, AYAs diagnosed with acute promyelocytic leukemia (9.6%, 95% CI\u00a0= 8.4 to 11.1) or other acute leukemias (13.3%, 95% CI = 10.5 to 16.7) had the highest proportion of early death and AYAs diagnosed with T lymphoblastic leukemia\/lymphoma had the lowest (2.6%, 95% CI = 1.9 to 3.7). Older age at diagnosis, male sex, and Hispanic ethnicity were all associated with increased risk of early death.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>A high proportion of AYAs with acute leukemia experience early death and risk varies by leukemia type and sociodemographic factors. A better understanding of the complex interplay between disease biology and sociodemographic factors is needed to guide risk prediction and prevention.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jncics\/pkaf065","type":"journal-article","created":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T01:13:52Z","timestamp":1751073232000},"source":"Crossref","is-referenced-by-count":3,"title":["Risk of early death after acute leukemia diagnosis among adolescents and young adults"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0650-3664","authenticated-orcid":false,"given":"Amy M","family":"Berkman","sequence":"first","affiliation":[{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital , Memphis, TN 38105,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1846-9117","authenticated-orcid":false,"given":"Clark R","family":"Andersen","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, The University of Texas MD Anderson Cancer Center , Houston, TX 77030,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9829-5841","authenticated-orcid":false,"given":"Vidya","family":"Puthenpura","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology and Oncology, Department of Pediatrics, Yale School of Medicine , New Haven, CT 06510,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J","family":"Short","sequence":"additional","affiliation":[{"name":"Department of Leukemia, The University of Texas MD Anderson Cancer Center , Houston, TX 77030,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Merriman","sequence":"additional","affiliation":[{"name":"Department of Cancer Registry, The University of Texas MD Anderson Cancer Center , Houston, TX 77030,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5959-397X","authenticated-orcid":false,"given":"Mahesh","family":"Swaminathan","sequence":"additional","affiliation":[{"name":"Department of Leukemia, The University of Texas MD Anderson Cancer Center , Houston, TX 77030,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branko","family":"Cuglievan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The University of Texas MD Anderson Cancer Center , Houston, TX 77030,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2297-9670","authenticated-orcid":false,"given":"David","family":"McCall","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The University of Texas MD Anderson Cancer Center , Houston, TX 77030,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9003-0390","authenticated-orcid":false,"given":"Courtney","family":"DiNardo","sequence":"additional","affiliation":[{"name":"Department of Leukemia, The University of Texas MD Anderson Cancer Center , Houston, TX 77030,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9701-8826","authenticated-orcid":false,"given":"Cesar","family":"Nunez","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The University of Texas MD Anderson Cancer Center , Houston, TX 77030,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0114-8384","authenticated-orcid":false,"given":"Nitin","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Leukemia, The University of Texas MD Anderson Cancer Center , Houston, TX 77030,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9892-9832","authenticated-orcid":false,"given":"Tapan","family":"Kadia","sequence":"additional","affiliation":[{"name":"Department of Leukemia, The University of Texas MD Anderson Cancer Center , Houston, TX 77030,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4339-8683","authenticated-orcid":false,"given":"Ghayas","family":"Issa","sequence":"additional","affiliation":[{"name":"Department of Leukemia, The University of Texas MD Anderson Cancer Center , Houston, TX 77030,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9146-4702","authenticated-orcid":false,"given":"Amber","family":"Gibson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The University of Texas MD Anderson Cancer Center , Houston, TX 77030,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2978-2267","authenticated-orcid":false,"given":"Miriam B","family":"Garcia","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The University of Texas MD Anderson Cancer Center , Houston, TX 77030,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1337-3282","authenticated-orcid":false,"given":"J Andrew","family":"Livingston","sequence":"additional","affiliation":[{"name":"Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX 77030,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0282-6490","authenticated-orcid":false,"given":"Susan","family":"Parsons","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology and Institute for Clinical Research and Health Policy Studies, Tufts Medical Center Cancer Center , Boston, MA 02111,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6769-6872","authenticated-orcid":false,"given":"Michelle A T","family":"Hildebrandt","sequence":"additional","affiliation":[{"name":"Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center , Houston, TX 77030,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6411-8353","authenticated-orcid":false,"given":"Michael E","family":"Roth","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The University of Texas MD Anderson Cancer Center , Houston, TX 77030,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"2025070408570608000_pkaf065-B1","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1200\/JCO.23.01367","article-title":"Survival trends among adolescents and young adults diagnosed with cancer in the United States: comparisons with children and older adults","volume":"42","author":"Keegan","year":"2024","journal-title":"J Clin Oncol"},{"key":"2025070408570608000_pkaf065-B2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/jnci\/djac206","article-title":"Risk of early death in adolescents and young adults with cancer: a population-based study","volume":"115","author":"Berkman","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"2025070408570608000_pkaf065-B3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3322\/caac.21637","article-title":"Cancer statistics for adolescents and young adults, 2020","volume":"70","author":"Miller","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"2025070408570608000_pkaf065-B4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcrc.2016.08.023","article-title":"The relationship between executive dysfunction, depression, and mental health-related quality of life in survivors of critical illness: results from the BRAIN-ICU investigation","volume":"37","author":"Duggan","year":"2017","journal-title":"J Crit Care"},{"key":"2025070408570608000_pkaf065-B5","author":"United States Environmental Protection Agency"},{"key":"2025070408570608000_pkaf065-B6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1023\/A:1011240019516","article-title":"Socioeconomic status and breast cancer incidence in California for different race\/ethnic groups","volume":"12","author":"Yost","year":"2001","journal-title":"Cancer Causes Control"},{"key":"2025070408570608000_pkaf065-B7","doi-asserted-by":"crossref","DOI":"10.1201\/9781420035933","volume-title":"Subset Selection in Regression","author":"Miller","year":"2002"},{"key":"2025070408570608000_pkaf065-B8","author":"Lambert"},{"key":"2025070408570608000_pkaf065-B9","doi-asserted-by":"crossref","DOI":"10.1201\/9781315370279","volume-title":"Generalized Additive Models: An Introduction with R.","author":"Wood","year":"2017","edition":"2nd ed"},{"key":"2025070408570608000_pkaf065-B10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0956797613504966","article-title":"The new statistics: why and how","volume":"25","author":"Cumming","year":"2014","journal-title":"Psychol Sci"},{"key":"2025070408570608000_pkaf065-B11","author":"Andersen","year":"2020"},{"key":"2025070408570608000_pkaf065-B12","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/leu.2009.12","article-title":"Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Munster study group","volume":"23","author":"Prucker","year":"2009","journal-title":"Leukemia"},{"key":"2025070408570608000_pkaf065-B13","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/cncr.20532","article-title":"Death during induction therapy and first remission of acute leukemia in childhood: the St Jude experience","volume":"101","author":"Rubnitz","year":"2004","journal-title":"Cancer"},{"key":"2025070408570608000_pkaf065-B14","doi-asserted-by":"crossref","first-page":"e28099","DOI":"10.1002\/pbc.28099","article-title":"Causes of early death and treatment-related death in newly diagnosed pediatric acute myeloid leukemia: recent experiences of the Dutch Childhood Oncology Group","volume":"67","author":"Klein","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"2025070408570608000_pkaf065-B15","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3109\/10428194.2013.850685","article-title":"Early deaths in pediatric acute leukemia: a population-based study","volume":"55","author":"Cheng","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"2025070408570608000_pkaf065-B16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/sj.leu.2403665","article-title":"Causes of death\u2014other than progressive leukemia\u2014in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience","volume":"19","author":"Slats","year":"2005","journal-title":"Leukemia"},{"key":"2025070408570608000_pkaf065-B17","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1182\/bloodadvances.2021004789","article-title":"Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide study","volume":"5","author":"Gill","year":"2021","journal-title":"Blood Adv"},{"key":"2025070408570608000_pkaf065-B18","first-page":"e12042","article-title":"Differentiation syndrome, a side effect from the therapy of acute promyelocytic leukemia","volume":"12","author":"Reyhanoglu","year":"2020","journal-title":"Cureus"},{"key":"2025070408570608000_pkaf065-B19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0740-2570(03)00031-5","article-title":"Classification of acute leukemias","volume":"20","author":"Brunning","year":"2003","journal-title":"Semin Diagn Pathol"},{"key":"2025070408570608000_pkaf065-B20","doi-asserted-by":"crossref","first-page":"101329","DOI":"10.1016\/j.beha.2021.101329","article-title":"Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage","volume":"34","author":"Montefiori","year":"2021","journal-title":"Best Pract Res Clin Haematol"},{"key":"2025070408570608000_pkaf065-B21","doi-asserted-by":"crossref","first-page":"24290","DOI":"10.1038\/s41598-021-03709-7","article-title":"The association of complex genetic background with the prognosis of acute leukemia with ambiguous lineage","volume":"11","author":"Huang","year":"2021","journal-title":"Sci Rep"},{"key":"2025070408570608000_pkaf065-B22","first-page":"22564","article-title":"The factors affecting early death after the initial therapy of acute myeloid leukemia","volume":"8","author":"Malkan","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"2025070408570608000_pkaf065-B23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1182\/hematology.2023000507","article-title":"Adolescents and young adults (AYAs) vs pediatric patients: survival, risks, and barriers to enrollment","volume":"2023","author":"Janardan","year":"2023","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"2025070408570608000_pkaf065-B24","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41375-021-01460-6","article-title":"Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology Group Study AALL0232","volume":"36","author":"Burke","year":"2022","journal-title":"Leukemia"},{"key":"2025070408570608000_pkaf065-B25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1182\/blood-2024-206581","article-title":"Evolution of survival disparities among adolescents and young adults with AML in the US","volume":"144","author":"Feliciano","year":"2024","journal-title":"Blood"},{"key":"2025070408570608000_pkaf065-B26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41375-023-02068-8","article-title":"Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)","volume":"38","author":"Ozga","year":"2024","journal-title":"Leukemia"},{"key":"2025070408570608000_pkaf065-B27","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/jha2.589","article-title":"Molecular characteristics and outcomes in Hispanic and non-Hispanic patients with acute myeloid leukemia","volume":"3","author":"Bradley","year":"2022","journal-title":"EJHaem"},{"key":"2025070408570608000_pkaf065-B28","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1182\/bloodadvances.2022007197","article-title":"Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia","volume":"6","author":"Muffly","year":"2022","journal-title":"Blood Adv"},{"key":"2025070408570608000_pkaf065-B29","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1182\/blood-2024-201485","article-title":"Clinical presentation and induction outcomes among hispanic and non-hispanic patients with acute promyelocytic leukemia","volume":"144","author":"Rosen","year":"2024","journal-title":"Blood"},{"key":"2025070408570608000_pkaf065-B30","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1186\/s12885-022-09547-8","article-title":"Factors that contribute to disparities in time to acute leukemia diagnosis in young people: an in depth qualitative interview study","volume":"22","author":"Ding","year":"2022","journal-title":"BMC Cancer"},{"key":"2025070408570608000_pkaf065-B31","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1182\/bloodadvances.2021005148","article-title":"Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials","volume":"5","author":"Hantel","year":"2021","journal-title":"Blood Adv"},{"key":"2025070408570608000_pkaf065-B32","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1182\/bloodadvances.2022007544","article-title":"High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML","volume":"6","author":"Larkin","year":"2022","journal-title":"Blood Adv"},{"key":"2025070408570608000_pkaf065-B33","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1002\/cncr.27684","article-title":"Association between insurance and socioeconomic status and risk of advanced stage Hodgkin lymphoma in adolescents and young adults","volume":"118","author":"Smith","year":"2012","journal-title":"Cancer"},{"key":"2025070408570608000_pkaf065-B34","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkad058","article-title":"Socioeconomic status and inequities in treatment initiation and survival among patients with cancer, 2011-2022","volume":"7","author":"Guadamuz","year":"2023","journal-title":"JNCI Cancer Spectr"},{"key":"2025070408570608000_pkaf065-B35","first-page":"741","article-title":"Oncologic emergencies: recognition and initial management","volume":"97","author":"Higdon","year":"2018","journal-title":"Am Fam Phys"},{"key":"2025070408570608000_pkaf065-B36","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1200\/JCO.20.00158","article-title":"Clinical practice guideline for systemic antifungal prophylaxis in pediatric patients with cancer and hematopoietic stem-cell transplantation recipients","volume":"38","author":"Lehrnbecher","year":"2020","journal-title":"J Clin Oncol"},{"key":"2025070408570608000_pkaf065-B37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1182\/hematology.2020000098","article-title":"Updates in infection risk and management in acute leukemia","volume":"2020","author":"Logan","year":"2020","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"2025070408570608000_pkaf065-B38","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1182\/blood-2022-163436","article-title":"A simplified patient care strategy to decrease early deaths in acute promyelocytic leukemia (APL): results of the ECOG-ACRIN EA9131 Trial","volume":"140","author":"Jillella","year":"2022","journal-title":"Blood"},{"key":"2025070408570608000_pkaf065-B39","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.3390\/cancers15133477","article-title":"The coagulopathy of acute promyelocytic leukemia: an updated review of pathophysiology, risk stratification, and clinical management","volume":"15","author":"Hermsen","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2025070408570608000_pkaf065-B40","author":"National Cancer Institute"},{"key":"2025070408570608000_pkaf065-B41","author":"National Cancer Institute"}],"container-title":["JNCI Cancer Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jncics\/advance-article-pdf\/doi\/10.1093\/jncics\/pkaf065\/63536725\/pkaf065.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jncics\/article-pdf\/9\/4\/pkaf065\/63536725\/pkaf065.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jncics\/article-pdf\/9\/4\/pkaf065\/63536725\/pkaf065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T12:57:17Z","timestamp":1751633837000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jncics\/article\/doi\/10.1093\/jncics\/pkaf065\/8169938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jncics\/pkaf065","relation":{},"ISSN":["2515-5091"],"issn-type":[{"value":"2515-5091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,6,20]]},"article-number":"pkaf065"}}